In a study of 335 cases of NSCLC, univariate analysis revealed that increased MCT1 expression in stromal cells corresponded significantly with poor disease-specific survival (p = 0.003), but increased MCT1 expression in cancer cells corresponded with a favorable DFS (p = 0.020). Here, SLC16A1 is linked to cancer.